Newsletter - Banner

Breadcrumb

Navigation Menu

Asset Publisher

At the heart of precision medicine

New translational collaboration aims to transform approach to heart muscle disease

Recipient of the 2020-2021 Dr. Margaret Becklake Fellowship: Mikashmi Kohli

A postdoctoral fellow from the RI-MUHC is recognized for international work on TB diagnostics

Webinar: Open Science in Action. “Open for science? See how patients are inspiring our research”

An Open Science webinar with a physician and a patient who will discuss the scientific, personal, technical and ethical challenges of an open access biobank that could potentially save lives.

Novel gene therapy trial offers hope to patients with rare metabolic disease

Samuel is the first Canadian and the ninth patient worldwide to participate in the second phase of a study using gene therapy to treat Glycogen storage disease type I, otherwise known as GSD.

Call for Applications: Executive Director and Chief Scientific Officer, Research Institute of the McGill University Health Centre (RI-MUHC)

The RI-MUHC is seeking a dynamic and strategic leader to serve as its next Executive Director and Chief Scientific Officer (ED/CSO)

Interdisciplinary Consortium Receives Grant to Develop Next-Generation Cell-Based Cancer Vaccines

Cell-based cancer vaccines are revolutionizing the treatment of previously incurable cancers

Three COVID-19 projects at the RI-MUHC to receive CIHR funding

A $109M fund aims to mitigate impact of the pandemic on care delivery in Canada and beyond, as well as contribute to better understanding of the disease

Reflecting on my Master’s in Experimental Medicine experience

Dermatology resident Abdulhadi Jfri shares his thoughts on undertaking a simultaneous Master’s degree

COVID-19 pandemic: Looking back to better tackle future challenges

In two recent studies, RI-MUHC researchers provide useful information for evaluating public health strategies

Canadian researchers work together to develop made-in-Canada COVID-19 testing capacity

The road towards Canadian testing capacity began in Montreal

ResearchMatch brings researchers together

Sixteen new matches made, eight project funded: life sciences researchers meet data scientists

Rifampin for Latent TB: Shorter and safer than the standard treatment, but also cheaper

A new study shows that rifampin regimen is cheaper than isoniazid for latent tuberculosis

Engaging in Research on Aging: How trainees and researchers connect with the CLSA (Webinar) (June 30, 2020)

In this webinar, four panelists will share their personal insights and experiences with the CLSA, showcasing opportunities to engage with Canada’s largest platform for research on aging.

Webinar: Immunity in our community - how to stay safe in the age of COVID (June 17, 2020)

Immunity in our community - how to stay safe in the age of COVID. Since the onset of the COVID-19 pandemic, the main theme at the forefront of everyone’s mind has been safety.

COVID-19 pandemic: the need for privacy and digital contact tracing

RI-MUHC researcher Abhinav Sharma calls for an approach emphasizing voluntary consent

Innovation Moves Online for the 2020 McGill Clinical Innovation Competition

RI-MUHC research team, Emily McDonald and Todd C. Lee, ties for Marika Zelenka Roy Innovation Prize

COVID-19 impact on cancer patients: MUHC researchers take part in a multinational study

Published in The Lancet, the study reveals cancer-specific factors associated with increased mortality

Why do some non-smokers get COPD while many heavy smokers don’t?

A new study highlights a strong risk factor for COPD related to lung development

Hydroxychloroquine not effective in preventing the development of COVID-19 when used as post-exposure prophylaxis

A new study suggests that hydroxychloroquine is not effective in preventing the development of COVID-19 in individuals exposed to SARS-CoV-2

Webinar: Coexisting with COVID - the new normal (June 10, 2020)

The MUHC Foundation is launching a new webinar series!

From PhD to Employee Forum generates insights and perspectives

Report shares participants’ solutions to career development challenges in the life sciences

Interim Leadership of the Research Institute of the MUHC

The Board of Directors of the RI-MUHC is pleased to announce the appointment of Dr. Miguel N. Burnier, Jr. to the position of Interim Executive Director and Chief Scientific Officer of the RI-MUHC